ParcelBio, a biotechnology company developing a new class of potent and durable mRNA medicines, today announced it has raised ...

A more effective vaccine technology may be on the horizon. In a new study in mice, researchers from the University of Copenhagen demonstrate that a simple addition to mRNA vaccines can significantly ...

SAN DIEGO, April 15, 2026 /PRNewswire/ -- Alida Biosciences today announced the launch of its EpiPlex™ Tri-Mod™ Service, enabling simultaneous detection and quantification of three key mRNA ...

RNA modifications have emerged as a pivotal area of focus in molecular biology and precision medicine. Recent breakthroughs highlight the dynamic nature of ...

Advanced analytics and artificial intelligence (AI) will help make mRNA vaccines and therapeutics better by allowing biopharma engineers to fine-tune the enzymes used to manufacture such products.

N4-Acetylation of cytidine (ac4C) is an mRNA modification that enhances cellular mRNA stability and translation. Most eukaryotic organisms catalyze ac4C using a homologue of human N-acetyltransferase ...

The United States may be losing its edge in mRNA technology­­. The technology, which powered life-saving COVID-19 vaccines and is now rocketing new cancer therapeutics forward, will soon undergo a ...

A team of researchers led by Dr. Kim V. Narry, director of the Center for RNA Research at the Institute for Basic Science (IBS), has uncovered a key cellular mechanism that affects the function of ...

The EMA has recommended updating Comirnaty 10 mg formulations, including JN.1, KP.2, and LP.8.1 versions, to allow COVID-19 vaccination in individuals aged 6 months or older.

The MarketWatch News Department was not involved in the creation of this content. SAN DIEGO, April 15, 2026 /PRNewswire/ -- Alida Biosciences today announced the launch of its EpiPlex(TM) Tri-Mod(TM) ...